SR One, the corporate venture capital arm of GlaxoSmithKline, has led a $30m funding round for London-based biotechnology company Pulmocide.
Deal is the first investment for the GP's recently opened Midlands office
Deal ends a five-year holding period for Cornerstone, which acquired Infoniqa SQL in 2012
Craig Hopwood joins the GP's northern team from HSBC, where he was a director
Lexington was previously reported to be considering acquiring up to €1.2bn in secondary commitments